BioLineRx Ltd.
BLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9 | -$61 | -$25 | -$27 |
| Dep. & Amort. | $4 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $2 |
| Stock-Based Comp. | $1 | $2 | $2 | $1 |
| Change in WC | -$22 | $15 | $1 | -$1 |
| Other Non-Cash | -$18 | $19 | -$5 | $0 |
| Operating Cash Flow | -$44 | -$23 | -$26 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | -$0 | $0 |
| Inv. Purchases | -$26 | -$48 | -$44 | -$78 |
| Inv. Sales/Matur. | $56 | $49 | $48 | $40 |
| Other Inv. Act. | -$0 | -$0 | $0 | -$0 |
| Investing Cash Flow | $29 | $1 | $4 | -$38 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $4 | -$2 | $6 | -$4 |
| Stock Issued | $16 | $14 | $14 | $50 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $3 | $0 | $11 |
| Financing Cash Flow | $21 | $15 | $20 | $58 |
| Forex Effect | $0 | -$0 | -$1 | $0 |
| Net Chg. in Cash | $6 | -$6 | -$2 | -$4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4 | $11 | $13 | $17 |
| End Cash | $10 | $4 | $11 | $13 |
| Free Cash Flow | -$44 | -$23 | -$27 | -$24 |